Skip to content
Review

AI Frameworks for the Early Detection and Management of Diabetic Retinopathy: A Real-World Application.

Sep 2026 · Current Drug Discovery Technologies · 0 citations
Medicine

TL;DR

AI tools under various names, such as IDx-DR, EyeArt, and Google's AI algorithm, are quick and price-effective tests using an AI solution for early diagnosis of DR in either developed or developing economies.

Abstract

Diabetic retinopathy (DR) is a condition that progressively affects the microvasculature, commonly seen in individuals with diabetes, which is a leading cause of visual impairment across the globe. Approximately one-third of people with diabetes will eventually develop DR, and it remains a public health issue because the retinal damage is irreversible if the disease continues to go undiagnosed and untreated. Although various screening methods exist, including fundus photography and optical coherence tomography (OCT), they are often limited as a result of availability and expertise required for diagnosis and management. Recent advancements in artificial intelligence (AI) are transforming DR screening and diagnosis. AI has demonstrated the potential to automate retinal image evaluation with accuracies that, in some studies, approach or exceed existing standards of care; however, reported performance varies across algorithms, datasets, and clinical settings, highlighting the need for cautious interpretation and further validation in diverse populations. Machine learning (ML) & deep learning (DL) models, particularly convolutional neural networks (CNNs), have been found to have excellent performance in identifying DR-related abnormalities, including mild, moderate, and severe DR, and diabetic macular edema, at sensitivities and specificities exceeding traditional screening. AI tools under various names, such as IDx-DR, EyeArt, and Google's AI algorithm, are quick and price-effective tests using an AI solution for early diagnosis of DR in either developed or developing economies. In addition, AI can also support predictive analytics, risk stratification, and treatment decision-making, so that ophthalmologists can provide patients with better management options. Importantly, AI also comes with its own challenges, such as data harmonization and regulatory approval for deploying AI in clinical care. This review will focus on the existing literature on the applications of AI in diagnosing and management of DR and will outline the importance of this innovation.

View source

Similar papers

Review Open access 2018

A Study on Diabetic Retinopathy Classification using Deep Learning Technique

Diabetic Retinopathy (DR) is a prevalent complication of diabetes mellitus, leading to retinal lesions that can cause vision impairment and even blindness if left undetected. The prevalence of diabetes worldwide has witnessed a significant increase in recent years, affecting individuals across all age groups. Early det...

H. Manjunatha, Shashidhara B · 0 citations
Review Open access 2026

ADVANCEMENTS IN AI-DRIVEN DIABETIC RETINOPATHY DETECTION: A SYSTEMATIC SURVEY OF METHODS, CHALLENGES, AND FUTURE DIRECTIONS

Diabetic retinopathy (DR) is a leading cause of preventable vision impairment, requiring scalable and reliable screening solutions. Artificial intelligence (AI), particularly machine learning and deep learning, has significantly advanced the automation of DR classification from retinal fundus images. This paper present...

Yasser A. Ali, Ahmed Emam, Muhammad H. Zayyan et al. · 0 citations
Conference

Deep Learning for Diabetic Retinopathy with Color Fundus Image Analysis in AI for Medical Imaging

This work analyzes clinical photos of diabetic retinopathy (DR), a common and preventable cause of vision impairment, using deep-learning methods. We have analyzed the computational efficiency of several concatenated CNN models, including DenseNet201, ResNet50, VGG19, and MobileNet V2. ResNet50 has a training time of 1...

M. B. A. Miah · 0 citations
Open access Sep 2026

Diabetic retinopathy screening using artificial intelligence: a comprehensive performance comparison on datasets from diverse populations and imaging modalities

The study highlights the impact of imaging equipment, demographics, and image quality on diagnostic performance and underscores the need for benchmarking AI-based DR screening tools using standardized datasets that encompass diverse populations and imaging conditions.

Philipp Schapotschnikow, Vladyslav Dusiak, Murat Osswald et al. · 0 citations
Open access Sep 2026

Optimizing Clinical Decision-Making through the Integration of MobileNetV2 and Explainable AI in a Diabetic Retinopathy Screening System

Diabetic Retinopathy is a severe diabetic complication and a leading cause of global blindness. While recent studies predominantly rely on computationally heavy deep learning models that evaluate images in isolation without considering patient clinical histories, their implementation in primary healthcare is frequently...

Muhammad Faiz Abror, Nanang Hoesen Hidroes Abbrori · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.